Skip to the page

Data / Form D filings / NeurOp, Inc.

NeurOp, Inc.: Form D filing

NeurOp, Inc., a biotechnology company in Atlanta, GA, filed a Form D with the SEC in 2014. The latest, on February 24, 2014, reports $155,000 sold of an offering with no set size to 5 investors.

Find out what NeurOp, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
58 EDGEWOOD AVENUE, NE, COLLABTECH, FIRST FLOOR, SUITE 117, Atlanta, GA, 30303
Phone
(919) 260-5595
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1600607

The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 24, 2014New noticeIndefinite$155,000Indefinite5Feb 7, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robert BonczekDirector
James McNamaraDirector
Dennis LiottaDirector
George KoszalkaExecutive Officer, Director
Raymond DingledineDirector

Other biotechnology companies in Georgia that filed recently

Every Form D from the week of Feb 24, 2014 · All recent filings in Georgia · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what NeurOp, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.